How many insider trades does FilingIQ track for NBP?

FilingIQ tracks 5 Form 4 insider transactions for NBP (NovaBridge Biosciences), covering filings from Apr 24, 2026 onwards. 5 of those were filed in the last 90 days.

Are NBP insiders net buyers or net sellers?

Across the full Form 4 history for NBP, 1 transactions (20%) were open-market purchases and 2 (40%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does NBP insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is NBP in?

NovaBridge Biosciences (NBP) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $276.40M.

NBP insider trading

NasdaqGM Healthcare

NovaBridge Biosciences — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

20% / 40%

Market cap

$276.40M

About NovaBridge Biosciences

NovaBridge Biosciences, a biotech company, focuses on the development of immuno-oncology agents for the treatment of cancer in the United States. The company is developing givastomig, a bispecific antibody, which is in Phase 1b clinical trial for the treatment of gastric cancer; uliledlimab, a CD73 neutralizing antibody; and ragistomig, a bispecific antibody, which is in phase 1 clinical trial for the treatment of solid tumors. It has a strategic licensing agreement with Ferring International Center SA to research, develop, make, have made, import, use, sell, and offer to sell FE301, an interleukin-6 inhibitor. The company also has collaborations with Bristol Myers Squibb for the development of givastomig; ABL Bio, Inc. for the development of givastomig and ragistomig; and TJ Bio for the development of uliledlimab. The company was formerly known as I-Mab and change its name to NovaBridge Biosciences in October 2025. NovaBridge Biosciences was founded in 2014 and is headquartered in Rockville, Maryland.

Company website: www.novabridge.com

NBP insider activity at a glance

FilingIQ has scored 5 insider transactions for NBP since Apr 24, 2026. The most recent filing in our index is dated Jun 1, 2026.

Across the full history, 1 open-market purchases and 2 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on NBP insider trades is 63.3/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live NBP trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,234

UNITED THERAPEUTICS Corp

APLS 277

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

GH 187

Guardant Health, Inc.

BMY 182

BRISTOL MYERS SQUIBB CO

HOLX 142

HOLOGIC INC

ADPT 140

Adaptive Biotechnologies Corp

KNSA 139

Kiniksa Pharmaceuticals International, plc

Frequently asked

How many insider trades does FilingIQ track for NBP?: FilingIQ tracks 5 Form 4 insider transactions for NBP (NovaBridge Biosciences), covering filings from Apr 24, 2026 onwards. 5 of those were filed in the last 90 days.
Are NBP insiders net buyers or net sellers?: Across the full Form 4 history for NBP, 1 transactions (20%) were open-market purchases and 2 (40%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does NBP insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is NBP in?: NovaBridge Biosciences (NBP) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $276.40M.

Methodology & sources

Every NBP insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.